A Non-Invasive Blood-Based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years

This new study demonstrates that a blood test used with imaging can improve breast cancer detection and substantially reduce the use of potentially unnecessary biopsies.

  • In cancer, nothing is more important than early and accurate diagnosis
  • Women under the age of 50 are likely to have difficult-to-interpret breasts, with a high rate of breast density
  • There is a need for additional tools to detect breast cancer and reduce potentially avoidable biopsy

ABSTRACT BACKGROUND:

Despite significant advances in breast imaging, the ability to detect breast cancer (BC) remains a challenge. To address the unmet needs of the current BC detection paradigm, two prospective clinical trials were conducted to develop a blood-based Combinatorial Proteomic Biomarker Assay (Videssa® Breast) to accurately detect BC and reduce false positives (FP) from suspicious imaging findings.

Learn more by downloading the publication from Clincal Breast Cancer journal

Publications.png

Download Publication